Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Paquet

Showing results (1-10 of 223) with videos related to

Pageof 23
Sort By:
La Revue Du Praticien|September 3, 2020
[Therapeutic perspectives in Alzheimer's disease]Claire Paquet
Medical Hypotheses|March 11, 2018
Could ryanodine receptor dysfunction be linked to PKR brain accumulations in Alzheimer's disease?Jacques Hugon, Claire Paquet
Expert Review of Neurotherapeutics|November 7, 2008
Targeting miRNAs in Alzheimer's diseaseJacques Hugon, Claire Paquet
La Revue Du Praticien|September 3, 2020
[Transcranial cerebral stimulation in Alzheimer's disease]Jacques Hugon, Claire Paquet
Morphologie : Bulletin De L'Association Des Anatomistes|December 7, 2007
[Molecular and therapeutic approaches of the Alzheimer's disease]Jacques Hugon, Claire Paquet
International Journal of Molecular Sciences|April 3, 2021
The PKR/P38/RIPK1 Signaling Pathway as a Therapeutic Target in Alzheimer's DiseaseJacques Hugon, Claire Paquet
Medical Hypotheses|February 24, 2007
Could non coding RNA be involved in Alzheimer's disease?Claire Paquet, Jacques Hugon
Frontiers in Neurology|August 25, 2015
Pro-Apoptotic Kinase Levels in Cerebrospinal Fluid as Potential Future Biomarkers in Alzheimer's DiseaseClaire Paquet, Julien Dumurgier, Jacques Hugon
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 3, 2014
Can we rely only on ratios of cerebrospinal fluid biomarkers for AD biological diagnosis?Sylvain Lehmann, Audrey Gabelle, Claire Paquet
Current Opinion in Clinical Nutrition and Metabolic Care|April 19, 2021
Ketogenic diet therapy in Alzheimer's disease: an updated reviewMatthieu Lilamand, François Mouton-Liger, Claire Paquet
Pageof 23

Showing results (1-10 of 223) with videos related to

Sort By:
Pageof 23
La Revue Du Praticien|September 3, 2020
[Therapeutic perspectives in Alzheimer's disease]Claire Paquet
Medical Hypotheses|March 11, 2018
Could ryanodine receptor dysfunction be linked to PKR brain accumulations in Alzheimer's disease?Jacques Hugon, Claire Paquet
Expert Review of Neurotherapeutics|November 7, 2008
Targeting miRNAs in Alzheimer's diseaseJacques Hugon, Claire Paquet
La Revue Du Praticien|September 3, 2020
[Transcranial cerebral stimulation in Alzheimer's disease]Jacques Hugon, Claire Paquet
Morphologie : Bulletin De L'Association Des Anatomistes|December 7, 2007
[Molecular and therapeutic approaches of the Alzheimer's disease]Jacques Hugon, Claire Paquet
International Journal of Molecular Sciences|April 3, 2021
The PKR/P38/RIPK1 Signaling Pathway as a Therapeutic Target in Alzheimer's DiseaseJacques Hugon, Claire Paquet
Medical Hypotheses|February 24, 2007
Could non coding RNA be involved in Alzheimer's disease?Claire Paquet, Jacques Hugon
Frontiers in Neurology|August 25, 2015
Pro-Apoptotic Kinase Levels in Cerebrospinal Fluid as Potential Future Biomarkers in Alzheimer's DiseaseClaire Paquet, Julien Dumurgier, Jacques Hugon
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 3, 2014
Can we rely only on ratios of cerebrospinal fluid biomarkers for AD biological diagnosis?Sylvain Lehmann, Audrey Gabelle, Claire Paquet
Current Opinion in Clinical Nutrition and Metabolic Care|April 19, 2021
Ketogenic diet therapy in Alzheimer's disease: an updated reviewMatthieu Lilamand, François Mouton-Liger, Claire Paquet
Pageof 23